...
首页> 外文期刊>Journal of Clinical Microbiology >Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
【24h】

Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies

机译:曲霉种类的流行病学和抗真菌药性分析:血液系统恶性肿瘤患者的环境和临床分离株之间的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. ABSTRACT Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collected all consecutive cases and clinical isolates of culture-positive proven/probable invasive aspergillosis patients from January 2016 to April 2018 and sampled the air inside and outside the hospital. Cryptic species-level identification of Aspergillus , antifungal susceptibilities, and cyp51 gene sequencing were performed, and clinical data were analyzed. This study was conducted as part of the Ca tholic Hematology Hospital F ungi E pidemiology (CAFé) study. A total of 207 proven/probable invasive aspergillosis and 102 clinical and 129 environmental Aspergillus isolates were included in this analysis. The incidence of proven/probable invasive aspergillosis was 1.3 cases/1,000 patient-days during the study period. Cryptic Aspergillus species accounted for 33.8%, with no differences in proportions between the clinical and environmental isolates. Section Nigri presented a high proportion (70.5%) of cryptic species, mainly from A. tubingensis and A. awamori : the former being dominant in environmental samples, and the latter being more common in clinical isolates ( P & 0.001). Of 91 A. fumigatus isolates, azole-resistant A. fumigatus was found in 5.3% of all A. fumigatus isolates. Three isolates presented the TR _(34)/L98H mutation of the cyp51A gene. Patients with invasive aspergillosis caused by azole-resistant A. fumigatus showed 100% all-cause mortality at 100 days. This study demonstrates the significant portion of cryptic Aspergillus species and clinical implications of azole resistance and underscores the comparison between clinical and environmental isolates.
机译:关于曲霉的流行病学和易感性的全球数据对于侵袭性曲霉病的管理至关重要。在这里,我们旨在确定临床和环境曲霉分离株的特征,主要针对血液系统恶性肿瘤患者。摘要有关曲霉菌的流行病学和药敏性的全球数据对于侵袭性曲霉病的管理至关重要。在这里,我们旨在确定临床和环境曲霉分离株的特征,主要针对血液系统恶性肿瘤患者。我们从2016年1月至2018年4月前瞻性收集了所有培养阳性,可能是侵袭性曲霉病患者的连续病例和临床分离株,并对医院内外的空气进行了采样。进行了曲霉菌的隐种鉴定,抗真菌药性和cyp51基因测序,并对临床数据进行了分析。这项研究是加拿大天主教医院流行病学(CAFé)研究的一部分。该分析总共包括了207种已证实/可能的侵袭性曲霉病,102种临床和129种环境曲霉菌分离株。在研究期间,已证实/可能的侵袭性曲霉病发生率为1.3例/ 1,000患者-天。隐性曲霉菌占33.8%,临床分离株和环境分离株之间的比例没有差异。 Nigri节呈现出高比例(70.5%)的隐性物种,主要来自塔宾曲霉和泡盛曲霉:前者在环境样品中占主导地位,而后者在临床分离株中更为常见(P <0.001)。在91种烟曲霉菌株中,在所有烟曲霉菌株的5.3%中发现了对唑类具有抗药性的烟曲霉。三个分离株呈现了cyp51A基因的TR_(34)/ L98H突变。由对唑类耐药的烟曲霉引起的侵袭性曲霉病患者在100天时显示100%的全因死亡率。这项研究证明了隐秘曲霉菌种的重要组成部分及其对吡咯耐药性的临床意义,并强调了临床分离株和环境分离株之间的比较。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号